Craft

Enzo Biochem

Stock Price

$1.1

2024-10-29

Market Capitalization

$58.1 M

2024-10-29

Revenue

$31.9 M

FY, 2024

Enzo Biochem Summary

Company Summary

Overview
Enzo Biochem is a biotechnology company specializing in the research, development, manufacturing, and marketing of diagnostic and research products that utilize genetic engineering, biotechnology, and molecular biology. It operates through Enzo Life Sciences segment. The Enzo Life Sciences segment manufactures, develops, and markets products and tools to clinical research, drug development, and bioscience research customers.
Type
Public
Status
Active
Founded
1976
HQ
Farmingdale, NY, US | view all locations
Website
https://www.enzo.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Patricia Eckert

    Patricia Eckert, Interim Chief Financial Officer

  • Kara Cannon

    Kara Cannon, Interim Chief Executive Officer

  • Steven J. Pully

    Steven J. Pully, Chairperson of the Board

    • Mary Tagliaferri

    Operating MetricsView all

    Patents Issued

    314

    FY, 2016

    Patents Pending

    146

    FY, 2016

    Facilities

    2

    FY, 2016

    LocationsView all

    4 locations detected

    • Farmingdale, NY HQ

      United States

      21 Executive Blvd

    • Ann Arbor, MI

      United States

      5777 Hines Dr

    • Farmingdale, NY

      United States

      10 Executive Blvd

    • Lausen, BL

      Switzerland

      Industriestrasse 17

    Enzo Biochem Financials

    Summary Financials

    Revenue (Q3, 2025)
    $6.4M
    Gross profit (Q3, 2025)
    $2.6M
    Net income (Q3, 2025)
    ($2.8M)
    Cash (Q3, 2025)
    $36.7M
    EBIT (Q3, 2025)
    ($3.4M)
    Enterprise value
    $24.5M

    Footer menu